NMRANeumora Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Neumora Therapeutics, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NMRAThis | $108M#14 | — | 2.4x#10 | — | — | -2.8%#8 | — | 532.2%#2 | -594.0%#4 | — | — | — |
| IVVD | $172M#1 | — | 1.0x#6 | 3.2x#6 | 110.5%#1 | 69.1%#5 | -104.0%#3 | -29.0%#4 | — | — | -63.5%#7 | — |
| LIMN | $169M#2 | — | 563.0x#12 | — | — | -187.8%#15 | — | -3395.2%#12 | -170.3%#2 | — | -96.2%#11 | — |
| STRO | $157M#3 | — | — | 1.5x#3 | 65.2%#2 | 15.9%#7 | -154.5%#4 | — | — | — | — | — |
| TARA | $144M#4 | — | 0.9x#5 | 48.7x#8 | — | -28.7%#10 | -2189.6%#8 | -35.6%#5 | — | — | -52.4%#4 | — |
| CMPX | $138M#5 | — | 0.8x#4 | — | -100.0%#6 | -34.7%#11 | — | -40.0%#6 | — | — | — | — |
| CHRS | $124M#6 | — | 2.0x#9 | 3.0x#5 | 59.8%#3 | 489.4%#1 | -429.5%#6 | 276.2%#3 | -351.2%#3 | — | -49.3%#3 | — |
| HUMA | $122M#7 | — | 3.9x#11 | 59.7x#9 | — | 72.5%#4 | -5306.0%#10 | -130.6%#11 | — | — | — | — |
| AVXL | $112M#11 | — | 1.0x#7 | — | — | -7.8%#9 | — | -41.2%#7 | — | — | — | — |
| OTLK | $112M#10 | — | — | 79.3x#10 | — | 17.2%#6 | -4744.3%#9 | — | -12.8%#1 | — | -64.7%#8 | — |
| LENZ | $110M#12 | — | 0.6x#2 | 5.8x#7 | — | -65.0%#12 | -477.5%#7 | -42.8%#8 | — | — | -87.5%#10 | — |
| VYGR | $113M#9 | — | 0.7x#3 | 2.8x#4 | -49.5%#5 | -84.2%#13 | -326.6%#5 | -77.6%#10 | — | — | -59.9%#6 | — |
| ARMP | $114M#8 | — | — | — | — | -818.8%#16 | — | — | — | — | -35.9%#1 | 0.1%#1 |
| BDTX | $104M#15 | — | 1.1x#8 | 1.5x#2 | — | 132.1%#3 | 17.9%#2 | 23276.9%#1 | — | — | -54.3%#5 | — |
| ENGN | $109M#13 | 0.6x#1 | 0.5x#1 | — | — | -112.7%#14 | — | -50.9%#9 | — | — | -76.5%#9 | — |
| ATRA | $85M#16 | — | — | 0.7x#1 | -6.3%#4 | 138.3%#2 | 29.7%#1 | — | — | — | -40.2%#2 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice